4C9 Stock Overview
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
CVS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£9.35 |
| 52 Week High | UK£20.00 |
| 52 Week Low | UK£9.30 |
| Beta | 1.08 |
| 11 Month Change | -13.43% |
| 3 Month Change | -29.17% |
| 1 Year Change | -45.00% |
| 33 Year Change | -63.90% |
| 5 Year Change | -24.78% |
| Change since IPO | 185.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4C9 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.1% | 0.4% | 1.3% |
| 1Y | -45.0% | 12.0% | 7.9% |
Return vs Industry: 4C9 underperformed the German Healthcare industry which returned 14.9% over the past year.
Return vs Market: 4C9 underperformed the German Market which returned 7.2% over the past year.
Price Volatility
| 4C9 volatility | |
|---|---|
| 4C9 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4C9 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 4C9's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 8,822 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
| 4C9 fundamental statistics | |
|---|---|
| Market cap | €708.93m |
| Earnings (TTM) | €31.50m |
| Revenue (TTM) | €778.17m |
22.5x
P/E Ratio0.9x
P/S RatioIs 4C9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4C9 income statement (TTM) | |
|---|---|
| Revenue | UK£647.30m |
| Cost of Revenue | UK£369.40m |
| Gross Profit | UK£277.90m |
| Other Expenses | UK£251.70m |
| Earnings | UK£26.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 42.93% |
| Net Profit Margin | 4.05% |
| Debt/Equity Ratio | 69.6% |
How did 4C9 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield22%
Payout RatioDoes 4C9 pay a reliable dividends?
See 4C9 dividend history and benchmarks| CVS Group dividend dates | |
|---|---|
| Ex Dividend Date | Oct 31 2024 |
| Dividend Pay Date | Nov 29 2024 |
| Days until Ex dividend | 29 days |
| Days until Dividend pay date | 0 days |
Does 4C9 pay a reliable dividends?
See 4C9 dividend history and benchmarks